Bristol Myers says second CELMoD succeeds in Phase 3
Bristol Myers says second CELMoD succeeds in Phase 3
Contenu indisponible. Consultez la source originale.
Bristol Myers says second CELMoD succeeds in Phase 3
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.